This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joel F. Waltzer, MD; Franklin P. Flowers, MD
Department of Medicine University of Florida College of Medicine Gainesville, FL 32610-0277; Department of Medicine Division of Dermatology and Cutaneous Surgery University of Florida College of Medicine Gainesville, FL 32610-0277

Arch Dermatol. 1993;129(1):43-45.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Chemotherapy-induced acral erythema (CIAE) is a rare response to cytotoxic agents that involves painful, well-demarcated erythematous plaques. These plaques usually occur on the palmar and dorsal surface of the hands and, less frequently, on the soles and dorsa of the feet. Some cases, however, progress to bullae formation with subsequent desquamation and sloughing.¹

After encountering a case of bullous CIAE, we discovered an interesting trend in our review of the literature. Patients in whom CIAE developed following treatment with cytarabine, alone or in combination with other agents, have a predilection to progress to the bullous form of CIAE.^2-6 Conversely, those patients receiving doxorubicin and/or fluorouracil are much more likely to have the nonbullous variation of acral erythema develop.

Report of a Case.—

A 31-year-old man with acute lymphocytic leukemia was admitted for an allogenic bone marrow transplantation. Induction therapy in preparation for undergoing the transplantation included cytarabine . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?